For: | Bodzin AS, Busuttil RW. Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol 2015; 7(9): 1157-1167 [PMID: 26019732 DOI: 10.4254/wjh.v7.i9.1157] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i9/1157.htm |
Number | Citing Articles |
1 |
Yogesh Kumar, Alugoju Phaniendra, Latha Periyasamy. Bixin Triggers Apoptosis of Human Hep3B Hepatocellular Carcinoma Cells: An Insight to Molecular and IN SILICO Approach. Nutrition and Cancer 2018; 70(6): 971 doi: 10.1080/01635581.2018.1490445
|
2 |
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
|
3 |
Shanshan Zhang, Jingxiao Wang, Haichuan Wang, Lingling Fan, Biao Fan, Billy Zeng, Junyan Tao, Xiaolei Li, Li Che, Antonio Cigliano, Silvia Ribback, Frank Dombrowski, Bin Chen, Wenming Cong, Lixin Wei, Diego F. Calvisi, Xin Chen. Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. The American Journal of Pathology 2018; 188(4): 995 doi: 10.1016/j.ajpath.2017.12.017
|
4 |
Wei Zhang, Jinzhen Cai, Bin Wu, Zhongyang Shen. pH-responsive hyaluronic acid nanoparticles coloaded with sorafenib and cisplatin for treatment of hepatocellular carcinoma. Journal of Biomaterials Applications 2019; 34(2): 219 doi: 10.1177/0885328219849711
|
5 |
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma. Cureus 2020; doi: 10.7759/cureus.9191
|
6 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations . World Journal of Clinical Cases 2023; 11(8): 1753-1760 doi: 10.12998/wjcc.v11.i8.1753
Abstract(586) |
Core Tip(464) |
Full Article(HTML)(1328)
|
Full Article (PDF)-1008K(141)
|
Full Article (Word)-308K(39)
|
Audio-126K(5)
|
Peer-Review Report-459K(61)
|
Answering Reviewers-161K(65)
|
Times Cited (0)
|
Total Visits (5336)
|
Open
|
7 |
Feng Wang, Houqun Ying, Bangshun He, Yuqin Pan, Huiling Sun, Shukui Wang. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Tumor Biology 2016; 37(4): 4945 doi: 10.1007/s13277-015-4340-z
|
8 |
Shanshan Jiang, Qian Wang, Meiqing Feng, Jiyang Li, Zhongbin Guan, Duopeng An, Mengxue Dong, Yuzhe Peng, Kudelaidi Kuerban, Li Ye. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. Applied Microbiology and Biotechnology 2017; 101(4): 1535 doi: 10.1007/s00253-016-7930-9
|
9 |
Arghadip Das, Supravat Das, Sanchari Bhattacharya, Debjeet Sur, Samrat Bose, Tilottama Mukherjee. Potential Oncotherapeutic Effects of Nutraceuticals against Hepatocellular
Carcinoma: Recent Advancements. Current Functional Foods 2023; 1(2) doi: 10.2174/2666862901666230215115849
|
10 |
Dimitra Repana, Paul Ross. Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. Diseases 2015; 3(4): 294 doi: 10.3390/diseases3040294
|
11 |
Shanshan Li, Yang Li, Hongjian Sun, Yang Jiang, Keming Pan, Yue Su, Nan Bu. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation. Bioengineered 2021; 12(2): 11599 doi: 10.1080/21655979.2021.1993716
|
12 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
|
13 |
Shahnaz Azzahra, Ulfa Kholili, Rosy Setiawati, Ummi Maimunah. Profile of Patients of Hepatocellular Carcinoma in The Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital . Current Internal Medicine Research and Practice Surabaya Journal 2023; 4(1): 1 doi: 10.20473/cimrj.v4i1.42287
|
14 |
Minghe Wang, Xuejing Wang, Yanqi Wang, Yikuo Gai, Jingran Ye, Xinyan Xu, Xue You. Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14674
|
15 |
Yulong Li, Xiaoli Zeng, Jianxun He, Yuan Gui, Song Zhao, Hua Chen, Qi Sun, Nan Jia, Hui Yuan. Circular RNA as a biomarker for cancer: A systematic meta‑analysis. Oncology Letters 2018; doi: 10.3892/ol.2018.9125
|
16 |
Yunzhen Gao, Gaoxiong Wang, Cuilin Zhang, Minjie Lin, Xiaolong Liu, Yongyi Zeng, Jingfeng Liu. Long non-coding RNA linc-cdh4-2 inhibits the migration and invasion of HCC cells by targeting R-cadherin pathway. Biochemical and Biophysical Research Communications 2016; 480(3): 348 doi: 10.1016/j.bbrc.2016.10.048
|
17 |
Jiapeng Chen, Alexandra Montagner, Nguan Soon Tan, Walter Wahli. Insights into the Role of PPARβ/δ in NAFLD. International Journal of Molecular Sciences 2018; 19(7): 1893 doi: 10.3390/ijms19071893
|
18 |
JianDe Gong, XuFei Qi, Yi Zhang, YingCong Yu, XiZhou Lin, HongLiang Li, YiRen Hu. Long noncoding RNA linc00462 promotes hepatocellular carcinoma progression. Biomedicine & Pharmacotherapy 2017; 93: 40 doi: 10.1016/j.biopha.2017.06.004
|
19 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
20 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
21 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María Martín, Alejandro Jiménez, Manuel Barrera. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(9): 1524 doi: 10.3390/ijms17091524
|
22 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Luca Di Tommaso, Arrigo Bondi, Sergio Sabbatani, Andrea Domanico, Carlo Fabbri, Paolo Leandri, Annalisa Pession, Elio Jovine, Dario de Biase. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World Journal of Gastroenterology 2016; 22(15): 3907-3936 doi: 10.3748/wjg.v22.i15.3907
|
23 |
Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharmaceutica 2017; 67(1): 1 doi: 10.1515/acph-2017-0007
|
24 |
Arvin Arian, Ayoob Dinar Abdullah, Hayder J Taher, Hayder Suhail Alareer, Maryam Fotouhi . Diagnostic Values of the Liver Imaging Reporting and Data System in the Detection and Characterization of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.36082
|
25 |
Gong Zhang, Ximin Chen, Lei Ma, Rui Ding, Lihong Zhao, Feng Ma, Xubin Deng. LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK. Aging 2020; 12(11): 11071 doi: 10.18632/aging.103321
|
26 |
Ying Ding, Sheng-xiang Rao, Wen-tao Wang, Cai-zhong Chen, Ren-chen Li, Mengsu Zeng. Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017). Cancer Imaging 2018; 18(1) doi: 10.1186/s40644-018-0183-3
|
27 |
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala. Systems Challenges of Hepatic Carcinomas: A Review. Journal of Clinical and Experimental Hepatology 2019; 9(2): 233 doi: 10.1016/j.jceh.2018.05.002
|
28 |
Yahui Zheng, Kangkang Yu, Chong Huang, Lu Liu, Hao Zhao, Meisi Huo, Jubo Zhang. Integrated bioinformatics analysis reveals role of the LINC01093/miR‑96‑5p/ZFAND5/NF‑κB signaling axis in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8046
|
29 |
Weitong Sun, Yong Wang, Mingyue Cai, Liteng Lin, Xiaoyan Chen, Zhong Cao, Kangshun Zhu, Xintao Shuai. Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy. Biomaterials Science 2017; 5(12): 2468 doi: 10.1039/C7BM00866J
|
30 |
Francesca M Trovato, Joshua M Tognarelli, Mary ME Crossey, Daniela Catalano, Simon D Taylor-Robinson, Guglielmo M Trovato. Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World Journal of Hepatology 2015; 7(26): 2664-2675 doi: 10.4254/wjh.v7.i26.2664
|
31 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Manuel A. Barrera. High serum soluble CD40L levels previously to liver transplantation in patients with hepatocellular carcinoma are associated with mortality at one year. Journal of Critical Care 2018; 43: 316 doi: 10.1016/j.jcrc.2017.09.032
|
32 |
Jia-Qi He, Min-Xia Zheng, Hua-Zhong Ying, Yu-Sen Zhong, Huan-Huan Zhang, Min Xu, Chen-Huan Yu. PRP1, a heteropolysaccharide from Platycodonis Radix, induced apoptosis of HepG2 cells via regulating miR-21-mediated PI3K/AKT pathway. International Journal of Biological Macromolecules 2020; 158: 542 doi: 10.1016/j.ijbiomac.2020.04.193
|
33 |
I‐Che Feng, Ming‐Ju Hsieh, Pei‐Ni Chen, Yi‐Hsien Hsieh, Hsin‐Yu Ho, Shun‐Fa Yang, Chao‐Bin Yeh. Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma. Environmental Toxicology 2018; 33(3): 261 doi: 10.1002/tox.22513
|
34 |
Jose Antonio Orellana TURRI, Tassia Cristina DECIMONI, Leandro Augusto FERREIRA, Marcio Augusto DINIZ, Luciana Bertocco de Paiva HADDAD, Alessandro Gonçalves CAMPOLINA. Higher MELD score increases the overall cost on the waiting list for liver transplantation: a micro-costing analysis based study. Arquivos de Gastroenterologia 2017; 54(3): 238 doi: 10.1590/s0004-2803.201700000-35
|
35 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Pedro Abreu-González, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Manuel A. Barrera. Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival. Journal of International Medical Research 2018; 46(7): 2641 doi: 10.1177/0300060518768150
|
36 |
Dan‐dan Xiong, Jian‐di Li, Rong‐quan He, Ming‐xuan Li, Yan‐qing Pan, Xiao‐lian He, Yi‐wu Dang, Gang Chen. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Medicine 2023; 12(4): 4938 doi: 10.1002/cam4.5186
|
37 |
Bo Du, Peng Zhang, Zhiming Tan, Jifan Xu. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14. Biomedicine & Pharmacotherapy 2017; 96: 1246 doi: 10.1016/j.biopha.2017.11.090
|
38 |
Hyun Joon An, Woo Young Shin, Keon-Young Lee, Seung-Ik Ahn. A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2015; 19(3): 89 doi: 10.14701/kjhbps.2015.19.3.89
|
39 |
C Cao, T Zhang, D Zhang, L Xie, X Zou, L Lei, D Wu, L Liu. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene 2017; 36(8): 1112 doi: 10.1038/onc.2016.278
|
40 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Manuel A. Barrera. Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality. Oncotarget 2018; 9(30): 21552 doi: 10.18632/oncotarget.25097
|
41 |
Hui Xie, Haipeng Yu, Shengtao Tian, Xueling Yang, Ximing Wang, Zhao Yang, Huaming Wang, Zhi Guo. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis. Oncotarget 2017; 8(59): 100508 doi: 10.18632/oncotarget.20119
|
42 |
Kumar Palaniappan, Vibhor V. Borkar, Mohamed Safwan, Mukul Vij, Sanjay Govil, Naresh Shanmugam, Mohamed Rela. Pediatric hepatocellular carcinoma in a developing country: Is the etiology changing?. Pediatric Transplantation 2016; 20(7): 898 doi: 10.1111/petr.12754
|
43 |
Dian-Gang Liu, Jing Chen, Hong-Xia Wang, Bao-Xin Li. Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma. Oncology Letters 2016; 12(6): 4961 doi: 10.3892/ol.2016.5344
|
44 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation. Expert Review of Molecular Diagnostics 2019; 19(7): 635 doi: 10.1080/14737159.2019.1619549
|
45 |
Xiao-Bo Lai, Yu-Qiang Nie, Hong-Li Huang, Ying-Fei Li, Chuang-Yu Cao, Hui Yang, Bo Shen, Zhi-Qiang Feng. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation. Oncology Letters 2017; 13(3): 1587 doi: 10.3892/ol.2017.5618
|
46 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation. World Journal of Hepatology 2022; 14(6): 1182-1189 doi: 10.4254/wjh.v14.i6.1182
|
47 |
Baoyi Jiang, Yulin Zhou, Yanting Liu, Siqi He, Baojian Liao, Tieli Peng, Leyi Yao, Ling Qi. Research Progress on the Role and Mechanism of IL-37 in Liver Diseases. Seminars in Liver Disease 2023; 43(03): 336 doi: 10.1055/a-2153-8836
|
48 |
Xin‐Xing Hu, Zhao‐Xia Yang, He‐Yue Liang, Ying Ding, Robert Grimm, Cai‐Xia Fu, Hui Liu, Xu Yan, Yuan Ji, Meng‐Su Zeng, Sheng‐Xiang Rao. Whole‐tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki‐67 labeling index. Journal of Magnetic Resonance Imaging 2017; 46(2): 383 doi: 10.1002/jmri.25555
|
49 |
Hongsheng Guo, Peng Li, Liudan Su, Kun Wu, Kai Huang, Ruizhi Lai, Jing Xu, Dingbao Sun, Shuxian Li, Ziliang Deng, Yan Wang, Haina Guo, Zhangquan Chen, Sen Wang. Low expression of IL-37 protein is correlated with high Oct4 protein expression in hepatocellular carcinoma. Gene 2020; 737: 144445 doi: 10.1016/j.gene.2020.144445
|
50 |
Brian McMahon, Joan Block, Timothy Block, Chari Cohen, Alison A. Evans, Anu Hosangadi, W. Thomas London, Morris Sherman. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care: Table 1.. Journal of the National Cancer Institute 2016; 108(4): djv359 doi: 10.1093/jnci/djv359
|
51 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
52 |
Benjamin Koh, Pojsakorn Danpanichkul, Meng Wang, Darren Jun Hao Tan, Cheng Han Ng. Application of artificial intelligence in the diagnosis of hepatocellular carcinoma. eGastroenterology 2023; 1(2): e100002 doi: 10.1136/egastro-2023-100002
|
53 |
Qiao Jin, Hao Hu, Siqi Yan, Long Jin, Yuliang Pan, Xiangjun Li, Yayi Peng, Peiguo Cao. lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.572585
|
54 |
Doha A. Mohamed, Karem Aly Fouda, Rasha S. Mohamed. In vitro Anticancer Activity of Quinoa and Safflower Seeds and Their Preventive Effects on Non-alcoholic Fatty Liver. Pakistan Journal of Biological Sciences 2019; 22(8): 383 doi: 10.3923/pjbs.2019.383.392
|
55 |
Lei Li, Jiangke Tian, Peng Liu, Xuan Wang, Zhenyu Zhu. Transarterial Chemoembolization Combination Therapy vs Monotherapy in Unresectable Hepatocellular Carcinoma: A Meta-Analysis. Tumori Journal 2016; 102(3): 301 doi: 10.5301/tj.5000491
|
56 |
Nur Şener, Abdullah Yakupoğlu. Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement. Medicine 2023; 102(35): e34674 doi: 10.1097/MD.0000000000034674
|
57 |
Lushan Xiao, Zixiao Zhou, Wenwen Li, Jie Peng, Qingcan Sun, Hongbo Zhu, Yang Song, Jin-Lin Hou, Jingyuan Sun, Hui-Chuan Cao, Dong Zhongyi, Dehua Wu, Li Liu. Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells. Aging 2019; 11(17): 7123 doi: 10.18632/aging.102241
|
58 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Pedro Abreu-González, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation. International Journal of Molecular Sciences 2019; 20(7): 1696 doi: 10.3390/ijms20071696
|
59 |
Chang Liu, Xiuli Mu, Xuan Wang, Chan Zhang, Lina Zhang, Baofeng Yu, Gongqin Sun. Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling. Molecules 2019; 24(7): 1363 doi: 10.3390/molecules24071363
|